New Fortress Energy Inc. Form 8-K Summary
Business context and reporting period
New Fortress Energy Inc. (NFE) filed a Form 8-K regarding material agreements entered into on January 13, 2021. The filing concerns proposed acquisitions of Hygo Energy Transition Ltd. and Golar LNG Partners LP (GMLP), together with related financing, support, and equity issuance arrangements. This is a transaction announcement and does not report a fiscal-period operating update.
Key transaction and financial terms
- Hygo acquisition: Hygo would become a wholly owned subsidiary of NFE. GLNG would receive 18.6 million NFE Class A shares and $50 million in cash. Stonepeak would receive 12.7 million NFE Class A shares and $530 million in cash.
- Hygo equity issuance: The filing specifies issuance of 18,627,451 shares to GLNG and 12,745,098 shares to Stonepeak, relying on the Securities Act Section 4(a)(2) exemption.
- GMLP acquisition: Each outstanding GMLP common unit would be converted into the right to receive $3.55 in cash. GMLP’s 8.75% Series A cumulative redeemable preferred units would remain outstanding, and general partner interests would remain outstanding after closing.
- GMLP general partner purchase: NFE’s indirect subsidiary would purchase all outstanding interests in GMLP’s general partner from GLNG for $5,099,188, equivalent to $3.55 per general partner unit.
- Financing: NFE obtained commitments for an aggregate $1.5 billion senior secured bridge term loan facility. The financing is intended to fund a portion of the GMLP cash consideration, refinance certain GMLP debt, and pay related fees and expenses if NFE does not issue some or all of $1.5 billion of senior secured notes.
- Liquidity and leverage: The filing does not provide NFE’s cash balance, debt balances, liquidity position, leverage ratios, interest expense, or pro forma capitalization.
Material changes versus the prior comparable period
The filing does not provide comparative revenue, profit, cash flow, margin, or balance-sheet information. The material changes disclosed are the proposed acquisitions, planned cash and equity consideration, assumed or refinanced GMLP debt, and the related financing commitments. The transactions had not closed as of the filing.
Guidance, outlook, risks, contingencies, and unusual items
- Closing of the Hygo merger is subject to regulatory approvals, specified third-party consents, absence of legal restraints and material adverse effects, accuracy of representations and warranties, covenant compliance, Nasdaq listing approval, and delivery of specified transition and shareholder agreements.
- Closing of the GMLP merger is subject to approval by the required majority of GMLP common unitholders, regulatory and third-party approvals, absence of legal restraints and material adverse effects, covenant compliance, and completion or waiver of the related general partner transfer conditions.
- The Hygo merger may generally be terminated if it has not closed by July 12, 2021. The GMLP merger may generally be terminated if it has not closed by July 13, 2021.
- Under specified circumstances, GMLP may owe NFE a $9.4 million termination fee and may be required to reimburse up to $2.5 million of certain expenses if the required unitholder approval is not obtained after the special meeting.
- GLNG and GMLP’s general partner agreed to support the GMLP merger by voting their common units in favor of the transaction and against competing or obstructive proposals, subject to modification if an adverse recommendation change occurs. GLNG beneficially owned approximately 30.8% of GMLP’s common units as of January 13, 2021.
- Management’s forward-looking statements identify risks including failure to obtain approvals or satisfy closing conditions, inability to complete or integrate the acquisitions, business disruption, employee retention issues, litigation, COVID-19 and other public health impacts, and failure to realize expected synergies.
- The filing provides no quantified revenue, earnings, cash-flow, margin, synergy, or post-closing guidance.
Most important facts for investors to verify
- Whether the Hygo and GMLP transactions closed, and the actual closing dates and final consideration.
- The number of NFE shares outstanding after the Hygo issuance and the resulting dilution to existing shareholders.
- The final sources and uses of funds, including senior notes, bridge financing, cash consideration, refinancing, and transaction expenses.
- The amount and terms of GMLP debt assumed or refinanced and the effect on NFE’s leverage and liquidity.
- Whether GMLP’s preferred units remained outstanding and the related distribution or redemption obligations.
- Actual operating and financial results of the acquired businesses, including revenue, profitability, cash flow, margins, and realized synergies.
- Subsequent SEC filings for regulatory approvals, litigation, termination rights, integration risks, and any changes to the transaction agreements.